Prescription drug · ANDA
Isosorbide Mononitrate NDC 0615-7767
Isosorbide mononitrate 30 mg/1 · Tablet, Extended release · Oral · NCS HealthCare of KY, LLC dba Vangard Labs
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0615-7767-05 | 0061577670500615776705 | 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-7767-05)Marketed from Feb 2, 2022 | |
| 0615-7767-39 | 0061577673900615776739 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-7767-39)Marketed from Feb 2, 2022 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Isosorbide Mononitrate
- Generic name (nonproprietary)
- isosorbide mononitrate
- Active ingredients
- Isosorbide mononitrate — 30 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- NCS HealthCare of KY, LLC dba Vangard LabsNDC labeler code 0615
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 200270
- Marketing start
- Listing expires
- Other FDA classes
- Nitrates (Chemical structure)Vasodilation (Physiologic effect)
- Identifiers
- Product ID 0615-7767_c8f05814-88ec-44f5-bf13-52590d9f9052SPL ID c8f05814-88ec-44f5-bf13-52590d9f9052SPL set ID 63dc518f-4f86-4820-98c2-5de8aed09a4bRxCUI 317110UNII LX1OH63030
- Pharmacologic class
- Nitrate Vasodilator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400615776705followed by a unit qualifier and the quantityPackage 00615-7767-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Isosorbide mononitrate extended-release tablets, USP are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.
Excerpt only. Read the full label for complete information.
About NDC 0615-7767
- What is NDC 0615-7767?
- 0615-7767 is the product NDC for Isosorbide Mononitrate, Isosorbide mononitrate 30 mg/1 tablet, extended release, listed with the FDA by NCS HealthCare of KY, LLC dba Vangard Labs. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Isosorbide Mononitrate.
- What is the active ingredient?
- Isosorbide mononitrate.
- Who is the labeler?
- NCS HealthCare of KY, LLC dba Vangard Labs, NDC labeler code 0615. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Isosorbide Mononitrate?
- 61 other product NDCs are listed under this name. See all Isosorbide Mononitrate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Isosorbide Mononitrate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Isosorbide Mononitrate | Isosorbide mononitrate 120 mg/1 | Tablet, Extended releaseOral | AiPing Pharmaceutical, Inc. | 11788-161 | 11788-0161-01 |
| Isosorbide Mononitrate | Isosorbide mononitrate 30 mg/1 | Tablet, Extended releaseOral | AiPing Pharmaceutical, Inc. | 11788-159 | 11788-0159-0111788-0159-0511788-0159-10 |
| Isosorbide Mononitrate | Isosorbide mononitrate 60 mg/1 | Tablet, Extended releaseOral | AiPing Pharmaceutical, Inc. | 11788-160 | 11788-0160-0111788-0160-0511788-0160-10 |
| Isosorbide Mononitrate | Isosorbide mononitrate 10 mg/1 | TabletOral | Coupler LLC | 67046-1687 | 67046-1687-03 |
| Isosorbide Mononitrate | Isosorbide mononitrate 20 mg/1 | TabletOral | Genus Lifesciences Inc. | 64950-251 | 64950-0251-01 |
| Isosorbide Mononitrate | Isosorbide mononitrate 10 mg/1 | TabletOral | Genus Lifesciences Inc. | 64950-250 | 64950-0250-01 |
| Isosorbide Mononitrate | Isosorbide mononitrate 10 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-252 | 62559-0252-01 |
| Isosorbide Mononitrate | Isosorbide mononitrate 20 mg/1 | TabletOral | ANI Pharmaceuticals, Inc. | 62559-253 | 62559-0253-01 |
| Isosorbide Mononitrate | Isosorbide mononitrate 60 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1632 | 67046-1632-03 |
| isosorbide mononitrate | Isosorbide mononitrate 20 mg/1 | TabletOral | Coupler LLC | 67046-1578 | 67046-1578-03 |
Other NDCs under ANDA 200270
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Isosorbide Mononitrate | Isosorbide mononitrate 30 mg/1 | Tablet, Extended releaseOral | Major Pharmaceuticals | 0904-6449 |
| Isosorbide Mononitrate | Isosorbide mononitrate 30 mg/1 | Tablet, Extended releaseOral | Torrent Pharmaceuticals Limited | 13668-104 |
| Isosorbide Mononitrate | Isosorbide mononitrate 30 mg/1 | Tablet, Extended releaseOral | Cardinal Health 107, LLC | 55154-7291 |
| Isosorbide Mononitrate | Isosorbide mononitrate 30 mg/1 | Tablet, Extended releaseOral | American Health Packaging | 60687-783 |
| Isosorbide Mononitrate | Isosorbide mononitrate 30 mg/1 | Tablet, Extended releaseOral | REMEDYREPACK INC. | 70518-2956 |